• Skip to main content
  • Skip to primary sidebar

Biotech Briefings

  • Home
  • About
  • Editors
  • Topics
  • Subscribe
  • Home
  • About
  • Editors
  • Topics
  • Subscribe
Jin Hee Kim

Jin Hee Kim

Partner, New York

jhkim@gibsondunn.com

+1 212.351.5371

Jin Hee is a finance partner in the New York office of Gibson Dunn. She has extensive experience advising sponsors, borrowers, arrangers, agents and lenders, including private credit providers on complex U.S. and international financing transactions.

View Full Profile

Royalty Finance Has Found Its Footing. Here’s What Six Years of Data Tell Us.

March 19, 2026 | Posted by Ryan A. Murr; Karen A. Spindler; Branden C. Berns; Jin Hee Kim; Topic(s): Royalty Finance; Trends and Insights

We just published Gibson Dunn’s 2026 Royalty Finance Market Update — a comprehensive analysis of 133 life sciences royalty transactions from 2020 through 2025, totaling $32.7 billion in aggregate value. A few findings stood out to us as genuinely worth flagging for practitioners in the space.

Read More

Primary Sidebar

Read our Life Sciences 2026 Outlook here.
Read our 2026 Royalty Finance Market Update here.

Topics

Antitrust

Capital Markets

Clinical Trials

CVR Spinoff

CVRs

Delaware Law

ECVC

False Claims Act

FDA

FDA Guidance

Government Regulation

International Trade

IPOs

License Agreements

M&A

Manufacturing

Reverse Mergers

Royalty Finance

SEC Disclosure

SEC Updates

Securities Litigation

Shareholder Activism

Tax

Trends and Insights

Editors

Rachel E. Baron

Branden C. Berns

Aaron K. Briggs

Jina L. Choi

Matt Donnelly

Pamela Lawrence Endreny

Gustav W. Eyler

Hui Fang

Carlo Felizardo

Mark Goldman

Bree Gong

Celina Jackson

Charlotte Jacobsen

Candice D. Johnson

Jin Hee Kim

Zaneta J. Kim

Wynne Leahy

Nicholas G. Linke

Jeff Lombard

Jane M. Love, Ph.D.

Mary Beth Maloney

Katlin McKelvie

Ryan A. Murr

Melanie E. Neary

John D.W. Partridge

Lindsay M. Paulin

Michael J. Perry

Jonathan M. Phillips

Ryan Rott

Lindsey D. Schmidt

Samantha Sewall

Sam Shapiro

Evan Shepherd

Eric B. Sloan

Adam M. Smith

Bradley P. Smith

Karen A. Spindler

Eric J. Stock

Ayushi Sutaria

Terrell Ussing

Jessica Valenzuela

Stephen Weissman

Kamia Williams

Useful Links

  • Gibson Dunn Website
  • Gibson Dunn Life Sciences Landing page
  • Securities Regulation and Corporate Governance Monitor
  • NVCA Model Legal Documents
  • Royalty Finance Tracker
  • Royalty Report: Royalty Finance Transactions in the Life Sciences 2020-2024
  • IPO Resource Center
  • IP Disputes and Litigation

Archives

Subscribe to Updates
RSS Feed
  • Privacy Statement
  • Cookie Notice
  • Contact Us
© 2025 Gibson, Dunn & Crutcher LLP. All rights reserved.